Redeye: Bredband2 - Q4 Review – Attractive Outlook
Redeye remains positive to Bredband2 following a Q4 2024 report in line with forecast. We continue to see solid growth prospects ahead and make mixed estimate adjustments for 2025-2026 with positive net effects. We increase our fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/